Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 223 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact223 DOIs

Add abstracts to 37 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact37 DOIs

Deposit reference lists for 15 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact15 DOIs

DOIs for this ISSN

Showing the top 5 of 743 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Eosinophilic airway inflammation: role in asthma and chronic… (10.1177/2040622315609251)	ORCID	61.29	282
2	Obstructive sleep apnoea syndrome and its management (10.1177/2040622315590318)	ORCID	59.90	248
3	Antipsychotic use in dementia: a systematic review of benefi… (10.1177/2040622316658463)	ORCID	59.73	244
4	Early onset type 2 diabetes: risk factors, clinical impact a… (10.1177/2040622314548679)	ORCID	58.36	215
5	Evidence for a protective effect of polyphenols-containing f… (10.1177/2040622311430006)	ORCID	57.85	205
6	Radiation-induced small bowel disease: latest developments a… (10.1177/2040622313510730)	ORCID	57.03	190
7	Treatment of painful diabetic neuropathy (10.1177/2040622314552071)	ORCID	56.50	181
8	Ketamine and other N-methyl-D-aspartate receptor antagonists… (10.1177/2040622315579059)	ORCID	56.38	179
9	Cognitive dysfunction with aging and the role of inflammatio… (10.1177/2040622311399145)	ORCID	55.10	159
10	Gastrointestinal bacterial overgrowth: pathogenesis and clin… (10.1177/2040622313496126)	ORCID	55.10	159
11	Secukinumab: a review of the anti-IL-17A biologic for the tr… (10.1177/2040622317738910)	ORCID	54.18	146
12	The diagnosis and treatment of chronic migraine (10.1177/2040622315579627)	ORCID	53.34	135
13	Effects of vitamin D on muscle function and performance: a r… (10.1177/2040622310381934)	ORCID	52.93	130
14	Strategies for dementia prevention: latest evidence and impl… (10.1177/2040622317712442)	ORCID	52.93	130
15	Interleukin 23 in the skin: role in psoriasis pathogenesis a… (10.1177/2040622318759282)	ORCID	52.76	128
16	Dimethyl fumarate in multiple sclerosis: latest developments… (10.1177/2040622316653307)	ORCID	52.16	121
17	Chronic obstructive pulmonary disease exacerbations: latest… (10.1177/2040622314532862)	ORCID	51.42	113
18	The emerging role of epigenetics in cardiovascular disease (10.1177/2040622314529325)	ORCID	51.13	110
19	The future role of gut hormones in the treatment of obesity (10.1177/2040622313506730)	ORCID	50.53	104
20	Update on the therapy of Behçet disease (10.1177/2040622314523062)	ORCID	49.89	98
21	Ponesimod, a selective S1P1 receptor modulator: a potential… (10.1177/2040622315617354)	ORCID	49.44	94
22	Bisphosphonates for the treatment of osteoporosis: insights… (10.1177/2040622310374783)	ORCID	49.09	91
23	Bedaquiline for the treatment of multidrug-resistant tubercu… (10.1177/2040622315582325)	ORCID	48.73	88
24	Opioid-induced constipation: advances and clinical guidance (10.1177/2040622315627801)	ORCID	48.61	87
25	Optimal treatment of laryngopharyngeal reflux disease (10.1177/2040622313503485)	ORCID	48.11	83
26	Long-acting muscarinic receptor antagonists for the treatmen… (10.1177/2040622313518227)	ORCID	47.30	77
27	Pharmacotherapy for obesity: novel agents and paradigms (10.1177/2040622314522848)	ORCID	47.30	77
28	Ocular itch associated with allergic conjunctivitis: latest… (10.1177/2040622315612745)	ORCID	47.02	75
29	New findings in osteoarthritis pathogenesis: therapeutic imp… (10.1177/2040622312462734)	ORCID	46.88	74
30	Prevention of infection caused by immunosuppressive drugs in… (10.1177/2040622313485275)	ORCID	46.43	71
31	Glaucoma management: relative value and place in therapy of… (10.1177/2040622313511286)	ORCID	46.43	71
32	Atypical femoral fractures and bisphosphonate use: current e… (10.1177/2040622315584114)	ORCID	46.28	70
33	Montelukast in asthma: a review of its efficacy and place in… (10.1177/2040622310383343)	ORCID	45.97	68
34	Contemporary treatment of systemic lupus erythematosus: an u… (10.1177/2040622310380100)	ORCID	45.81	67
35	Prospects for treating osteoarthritis: enzyme–protein intera… (10.1177/2040622312454157)	ORCID	45.65	66
36	Latest evidence on gout management: what the clinician needs… (10.1177/2040622312462056)	ORCID	44.98	62
37	Haemorrhoids: an update on management (10.1177/2040622317713957)	ORCID	44.98	62
38	Pegylated interferon and ribavirin treatment for hepatitis C… (10.1177/2040622310384308)	ORCID	44.63	60
39	Hypertension in women: latest findings and clinical implicat… (10.1177/2040622312438935)	ORCID	44.45	59
40	Management of cirrhotic ascites (10.1177/2040622315580069)	ORCID	44.45	59
41	Ezetimibe: an update on its clinical usefulness in specific… (10.1177/2040622316672544)	ORCID	44.45	59
42	Patient-reported functioning in major depressive disorder (10.1177/2040622316639769)	ORCID	44.27	58
43	Acute severe ulcerative colitis: latest evidence and therape… (10.1177/2040622317742095)	ORCID	44.09	57
44	Cardiovascular impact of drugs used in the treatment of diab… (10.1177/2040622314546125)	ORCID	43.90	56
45	Therapeutic benefits of budesonide in gastroenterology (10.1177/2040622310379293)	ORCID	43.70	55
46	Impact of air quality on lung health: myth or reality? (10.1177/2040622315587256)	ORCID	43.51	54
47	The prevalence and clinical characteristics associated with… (10.1177/2040622315627805)	ORCID	43.51	54
48	Thrombolysis in acute ischaemic stroke: an update (10.1177/2040622310394032)	ORCID	43.31	53
49	Lubiprostone in constipation: clinical evidence and place in… (10.1177/2040622314567678)	ORCID	43.31	53
50	Psoriatic arthritis: latest treatments and their place in th… (10.1177/2040622315582354)	ORCID	43.31	53